Skip to content
Search

Latest Stories

SPONSORED: Bestway Medhub and the benefits of telesales – looking after our pharmacy clients so they can look after their customers

By Sarah Gaughan

Telesales. We know it gets a bad rap. But the current supply volatility and pricing issues in the medicines supply chain are having a very negative impact for pharmacies, often impacting people on a daily basis – and telesales is helping to bridge that gap.


Historically, the role of a telesales executive was to process daily orders for customers and to promote the wholesaler’s product range, however, our Bestway Medhub telesales role has now evolved, offering an invaluable full account management service.

Sarah Gaughan Sarah Gaughan is office sales manager at BestWay Medhub

Our team offer a vital service. They now provide a crucial daily insight to our pharmacy customers, advising on market shortages, potential price increases and the day-to-day challenges faced by our procurement team.

This helps our customers manage and determine when they may need to make additional purchases to stay ahead of the market, purchasing products below drug tariff and offering supply continuity to patients.

Without this daily telephone interaction, our pharmacy customers may struggle to manage their stock levels effectively to ensure they can fulfil their patients’ prescriptions.

Bestway Medhub customers often compliment us on the efficiency of our telesales team and the lengths the team go to in looking after them, often going the extra mile to help the customer cope with all the challenges they face with the medicine supply chain.  The benefits of this service are endless.

For more information visit: bestwaymedhub.co.uk

Email: sales@bestwaymedhub.co.uk Call: 0800 050 1055

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less